Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-03-19, Stock:LLY, The news for the past five days is as follows:
2018-03-12: NEWS1: East Bay company's stock plummets 81% as drug for cystic fibrosis patients fails.NEWS2: Noteworthy Monday Option Activity: LLY, SWKS, HCA.NEWS3: Noteworthy Monday Option Activity: LLY, SWKS, HCA.NEWS4: The Zacks Analyst Blog Highlights: Coca-Cola, Eli Lilly, Occidental Petroleum, Ross Stores and Wynn Resorts.NEWS5: The Zacks Analyst Blog Highlights: Coca-Cola, Eli Lilly, Occidental Petroleum, Ross Stores and Wynn Resorts.NEWS6: The Zacks Analyst Blog Highlights: Coca-Cola, Eli Lilly, Occidental Petroleum, Ross Stores and Wynn Resorts.NEWS7: What Were AstraZeneca’s Growth Platforms in 4Q17?.
2018-03-13: NEWS1: &quot;Fast Money&quot; final trades: TGT, GLD and more.NEWS2: How Merck’s Diabetes Portfolio Performed in 2017.NEWS3: What’s Novartis’s Valuation in March 2018?.NEWS4: Eli Lilly Pleased With Uptake for Breast Cancer Drug Verzenio, Says Exec.NEWS5: How Did Merck Perform in 4Q17 and Fiscal 2017?.NEWS6: See what the IHS Markit Score report has to say about Eli Lilly And Co..
2018-03-14: NEWS1: Cramer's lightning round: Hidden giant Cintas is one of m....NEWS2: AVEO Pharmaceuticals (AVEO) Q4 Loss Widens, Shares Down.NEWS3: AVEO Pharmaceuticals (AVEO) Q4 Loss Widens, Shares Down.NEWS4: Merck's Keytruda Gets Priority Review for Cervical Cancer.NEWS5: Merck's Keytruda Gets Priority Review for Cervical Cancer.NEWS6: What Happened with Merck’s Keytruda in 2017?.NEWS7: Your first trade for Wednesday, March 14.NEWS8: Your first trade for Wednesday, March 14.
2018-03-15: NEWS1: Analysts’ Recommendations for Eli Lilly in March 2018.NEWS2: Update on Eli Lilly’s Oncology Drugs Erbitux, Gemzar, Lartruvo.NEWS3: Performance of Eli Lilly’s Oncology Drugs Alimta, Cyramza in 2017.NEWS4: Update on Eli Lilly’s Neuroscience Portfolio.NEWS5: Eli Lilly’s Immunology Business Saw Solid Growth in 2017.NEWS6: Eli Lilly’s Endocrinology Drugs Humalog, Humatrope, and Humulin.NEWS7: A Look at Eli Lilly’s Endocrinology Business in 2017.NEWS8: A Post-4Q17 Update on Eli Lilly’s Cardiovascular Business.NEWS9: Eli Lilly’s Jardiance, Trajenta, and Trulicity in 2017.NEWS10: Eli Lilly’s Performance in Fiscal 4Q17 and Fiscal 2017.NEWS11: Pfizer’s Valuation Post-4Q17 Earnings.NEWS12: How Pfizer Plans to Move Into the Big Leagues for Cancer Treatment.NEWS13: How Pfizer Plans to Move Into the Big Leagues for Cancer Treatment.NEWS14: How Pfizer Plans to Move Into the Big Leagues for Cancer Treatment.NEWS15: Capitol to Capital: Cramer's 'Mad Money' Recap (Wednesday 3/14/18).
2018-03-16: NEWS1: Is Eli Lilly and Company (LLY) Stock a Good Value Pick Now?.NEWS2: Is Eli Lilly and Company (LLY) Stock a Good Value Pick Now?.NEWS3: Is Eli Lilly and Company (LLY) Stock a Good Value Pick Now?.NEWS4: How Pfizer Performed across Geographies during 4Q17.

Answer: Decrease